Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides
US7230019B2 · kind B2 · utility
1Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2002 |
| Grant date | Jun 12, 2007 |
| Priority date | — |
| Expiry date | Apr 14, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds of Formula (I) and the use of compounds of Formula (I) as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.